The significance of Circadian Rhythms in Regulating Immune Function and its Implications for Autoimmune Diseases

e-ISSN: 0975-5160, p-ISSN: 2820-2651 Available online on www.ijtpr.com International Journal of Toxicological and Pharmacological Research 2024; 14 (12); 214-220 Dar et al. International Journal of Toxicological and Pharmacological Research 214 Original Research Article The significance of Circadian Rhythms in Regulating Immune Function and its Implications for Autoimmune Diseases Javed Hussain Bhat1, Soobia Rashid2, Mohd Abass Dar3, Kashif Naem Siddiqqi4 1,2Senior Resident, Department of Physiology, SKIMS Bemina, Srinagar 3Senior Resident, Department of Physiology, GMC Doda, Jammu 4Assistant Professor, Department of Biochemistry, MMC, Madhubani, Bihar Received: 18-09-2024 / Revised: 21-10-2024 / Accepted: 26-11-2024 Corresponding author: Dr. Mohd Abass Dar Conflict of interest: Nil Abstract: Circadian rhythms are endogenous; near-24-hour biological cycles that regulate diverse physiological processes, including immune function. These rhythms, orchestrated by central and peripheral molecular clocks, profoundly influence immune system dynamics, including leukocyte trafficking, cytokine secretion, and adaptive immune responses. Disruption of circadian rhythms, whether through genetic mutations, environmental influences, or lifestyle factors, has been increasingly implicated in the pathogenesis of autoimmune diseases. This review explores the intricate relationship between circadian biology and immune regulation, focusing on its role in autoimmune disease progression. We discuss emerging strategies, including chronotherapy, lifestyle modifications, and novel therapeutic targets, that leverage circadian principles to improve autoimmune disease management. Key words: Chronotherapy, cytokine, autoimmune, traffickling, erythematosus. This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided original work is properly credited. Introduction Autoimmune diseases, characterized by the immune system’s erroneous attack on self-antigens, represent a significant public health burden. The complex etiology of these diseases involves a combination of genetic predisposition, environmental triggers, and immune dysregulation. Recent advances in chronobiology have unveiled a critical role for circadian rhythms in maintaining immune homeostasis. Circadian disruption has been linked to exacerbated inflammation, impaired immune tolerance, and heightened susceptibility to autoimmune conditions such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and multiple sclerosis (MS). This manuscript aims to elucidate how circadian rhythms influence immune function and to propose circadian-based interventions as a novel paradigm in autoimmune disease management. Circadian Regulation of Immune Function: A. Cellular and Molecular Mechanisms: 1. Central and Peripheral Clock Systems: Circadian rhythms are governed by a master clock located in the suprachiasmatic nucleus (SCN) of the hypothalamus. This central clock coordinates peripheral clocks in various tissues, including immune cells, through hormonal, neural, and molecular signaling.[3] The molecular clock machinery involves core clock genes (CLOCK, BMAL1, PER, and CRY), which regulate the expression of downstream genes involved in immune pathways. 2. Immune Oscillations and Rhythmic Activity: • Leukocyte Trafficking: Immune cells, including neutrophils and monocytes, follow circadian patterns in their migration and tissue infiltration, with heightened activity during periods of rest to support tissue repair. Neutrophils and monocytes exhibit circadiandependent migration, peaking during the active phase (day in humans, night in mice). This rhythm is regulated by CXCL12 chemokine oscillations in bone marrow, controlled by adrenergic signaling from the SCN. • Adaptive Immunity: Antigen presentation by dendritic cells and T-cell activation exhibit circadian modulation, ensuring an optimized immune response at appropriate times of the day. CD8+ T cells show enhanced proliferation and cytotoxicity during the active phase, driven by BMAL1-dependent metabolic reprogramming (e.g., glycolysis upregulation). 3. Cytokine Dynamics: International Journal of Toxicological and Pharmacological Research e-ISSN: 0975-5160, p-ISSN:2820-2651 Daret al. International Journal of Toxicological and Pharmacological Research 215 • Pro-Inflammatory Cytokines: IL-6 and TNFα levels peak in early morning in humans, coinciding with cortisol’s anti-inflammatory nadir. Cortisol’s circadian surge at dawn suppresses NF-κB activity, while melatonin (secreted nocturnally) enhances TH1 responses. • Anti-Inflammatory Signals: IL-10 production by regulatory T cells peaks at night, balancing daytime inflammatory activity. A. Impacts of Circadian Disruption: 1) Chronic Inflammation: • Shift workers exhibit elevated CRP and IL-6 levels, correlating with a 30% increased risk of cardiovascular disease. • Mouse models of jet lag show persistent NFκB activation in hepatocytes, driving insulin resistance. 2) Immune Suppression:Sleep deprivation reduces influenza vaccine efficacy by 50% due to impaired CD4+ T cell memory. - Nightshift nurses have decreased NK cell activity, heightening susceptibility to viral infections. 3) Autoimmunity: • Rotating shift workers face a 1.4-fold higher risk of rheumatoid arthritis, linked to disrupted cortisol rhythms and IL-17 overproduction. • Per2 mutant mice develop spontaneous colitis due to deregulated gut Th17/ Treg balance. Circadian Dysregulation and Autoimmune Diseases: 1) Pathophysiological Impact of Circadian Misalignment: • Circadian disruption, caused by irregular sleepwake cycles, shift work, or light exposure at night, results in immune dysregulation: • Chronic Inflammation: Loss of rhythmic control over pro-inflammatory pathways promotes sustained inflammation, a key feature of autoimmune diseases. • Impaired Immune Tolerance: Dysregulated T-cell and B-cell activity, coupled with aberrant antigen presentation, can trigger autoimmunity. Figure 1: shows the mechanism of circadian regulation in the suprachiasmatic nucleus and its general effects on immune cell responses and sleep deprivation.[1] Figure1: The mechanism of circadian regulation in the suprachiasmatic nucleus and its general effects on immune cell responses and sleep deprivation (Original figure created with biorender.com by HH). BMAL-1 = brain and muscle ARNT-like 1, CLOCK = circadian locomotor output cycles kaput, CRY = cryptochrome circadian regulator, PER = period circadian regulator, Rev-Erb = reverse orientation cErbA gene α, ROR = retinoic acid-related orphan receptor, SCN = suprachiasmatic nucleus.[1] 2) Hormonal Contributions: • Circadian-regulated hormones such as cortisol and melatonin are vital for immune homeostasis: • Cortisol: This glucocorticoid suppresses inflammation and peaks early in the morning. Circadian misalignment may blunt this peak, leading to uncontrolled inflammation.[4] • Melatonin: Its nocturnal rise has antiinflammatory and immunomodulatory effects. Reduced melatonin levels, due to disrupted sleep or light exposure, are associated with heightened autoimmunity.[5] International Journal of Toxicological and Pharmacological Research e-ISSN: 0975-5160, p-ISSN:2820-2651 Daret al. International Journal of Toxicological and Pharmacological Research 216 3) Genetic and Epigenetic Factors: • Clock Gene Mutations: Variants in clock genes (BMAL1, PER3) have been linked to an increased risk of autoimmune conditions.[6] • Epigenetic Modifications: Environmental factors such as stress or diet can alter the circadian regulation of immune-related genes, exacerbating autoimmune disease progression.[7] Leveraging Circadian Biology for Autoimmune Disease Management: 1) Chronotherapy: Chronotherapy, the administration of treatments timed to the body’s circadian rhythms, offers significant potential: • Glucocorticoids: Administering glucocorticoids in the early morning aligns with natural cortisol peaks, enhancing antiinflammatory effects while reducing side effects.[8] • Immunosuppressants:Timing immunosuppressive drugs to periods of heightened immune activity, such as early evening, may optimize their efficacy in diseases like RA and SLE.[9] 2) Lifestyle Interventions: Lifestyle changes that align with circadian biology can mitigate autoimmune disease severity: • Sleep Optimization: Maintaining consistent sleep schedules enhances circadian regulation of immune function and reduces inflammatory markers. • Light Exposure Management: Exposure to natural light in the morning and minimizing blue light at night can help synchronize the central clock.[10] • Meal Timing: Regular, consistent meal times support peripheral clock synchronization, which is critical for metabolic and immune system coordination.[11] 3) Targeting Clock Genes:Innovative therapies aimed at modulating clock genes hold promise: • Clock Gene Modulators: Small molecules targeting clock proteins (BMAL1 activators, PER inhibitors) could restore circadian control over immune responses.[12] • Gene Editing: Emerging technologies like CRISPR-Cas9 could correct clock gene mutations in individuals predisposed to autoimmune diseases.[13] Figure 2: Role of melatonin and cortisol in circadian rhythm (created with BioRender.com).[2] 4) Chrononutrition: The timing of dietary intake influences circadian regulation of immune pathways: • Intermittent Fasting: Aligning fasting periods with circadian cycles may enhance anti-inflammatory pathways and immune tolerance.[13] • Nutrient Timing: Specific nutrients, such as omega-3 fatty acids and polyphenols, can modulate circadian rhythms and reduce inflammation.[14] International Journal of Toxicological and Pharmacological Research e-ISSN: 0975-5160, p-ISSN:2820-2651 Daret al. International Journal of Toxicological and Pharmacological Research 217 Future Directions: 1. Biomarkers for Circadian Health: The identification and development of biomarkers for circadian health is a critical area of research with significant potential to enhance the diagnosis, monitoring, and treatment of autoimmune diseases. Biomarkers that reflect circadian rhythm disruption or immune dysregulation could guide clinical decisions and allow for more precise interventions.[15] Molecular Biomarkers: Biomarkers such as clock gene expression levels (BMAL1, PER, CRY) in peripheral blood cells can provide insights into circadian rhythm alignment. For instance, analyzing circadian oscillations in transcriptomics or proteomics data may reveal specific time-dependent immune signatures that correlate with disease severity.[16] Hormonal Biomarkers: • Hormonal markers such as cortisol, melatonin, and cytokine secretion (e.g., IL-6, TNF-α) exhibit circadian oscillations.[17] Measuring their levels at different times of the day could provide a dynamic view of circadian regulation and immune activity.[18] • Example: Cortisol dysregulation has been shown to correlate with disease flare-ups in rheumatoid arthritis and systemic lupus erythematosus.[19] Cellular Biomarkers:Monitoring the circadian dynamics of immune cells, such as T-cells, Bcells, and monocytes, could reveal shifts in immune homeostasis. Techniques like flow cytometry combined with time-of-day sampling can uncover patterns of immune dysregulation associated with autoimmune diseases. Digital Biomarkers:Wearable devices and digital tools capable of tracking sleep-wake patterns, heart rate variability, body temperature, and light exposure offer non-invasive ways to assess circadian health.[20] Longitudinal data from these devices can be integrated into treatment plans to monitor disease activity in real-time.[21] The ultimate goal is to develop composite biomarker panels that combine molecular, hormonal, cellular, and digital inputs for a comprehensive understanding of circadian health in autoimmune diseases.[22] 2. Personalized Chronotherapy: The variability in circadian rhythms among individuals necessitates personalized approaches to chronotherapy for autoimmune disease management.[23]. Tailoring treatment to a patient’s unique circadian profile can enhance efficacy while reducing side effects.[24] Chronotyping Patients: Patients can be classified into chronotypes (e.g., morning larks, night owls) using questionnaires like the Morningness-Eveningness Questionnaire (MEQ) and biomarkers such as melatonin onset timing. [25].This information can inform the timing of medication and lifestyle interventions. Dynamic Treatment Schedules: • Advanced chronotherapy requires the optimization of drug dosing schedules based on individual circadian rhythms.[26] • Example: Administering anti-inflammatory drugs like glucocorticoids in the early morning aligns with the natural cortisol peak, enhancing their effectiveness.[27] Case Study Potential: Evening doses of immunosuppressants could be optimized to coincide with heightened immune cell activity, mitigating autoimmune flare-ups.[28] AI-Driven Personalization: Artificial intelligence (AI) and machine learning algorithms can analyze a patient’s circadian biomarkers, lifestyle data, and disease progression to recommend personalized treatment schedules.[29] Such AI-powered platforms can dynamically adapt to changes in a patient’s circadian profile, offering precision medicine approaches.[30] 3. Systems Biology Approaches: The integration of systems biology into circadian and autoimmune research provides a holistic framework for understanding complex interactions between molecular, cellular, and environmental factors.[31] Mathematical Modeling: • Computational models can simulate circadian rhythms at the molecular and systemic levels, predicting how disruptions influence immune function.[32] • Examples: Models incorporating clock gene dynamics and cytokine signaling pathways can predict the onset of autoimmune flares based on circadian misalignment.[33] Multi-Omics Approaches: • Systems biology integrates data from genomics, transcriptomics, proteomics, and metabolomics to identify circadian-regulated pathways in autoimmune diseases.[34] • Key Findings: Multi-omics data have revealed rhythmic patterns in metabolism that intersect with immune regulation, such as the role of lipid metabolism in T-cell function.[35] International Journal of Toxicological and Pharmacological Research e-ISSN: 0975-5160, p-ISSN:2820-2651 Daret al. International Journal of Toxicological and Pharmacological Research 218 Data Integration Tools: The integration of diverse data sources (e.g., biomarker profiles, wearable device outputs, and clinical outcomes) into cohesive models provides actionable insights.[36]. This approach can help identify novel therapeutic targets, such as pathways modulated by clock genes, and test interventions in silico before clinical trials.[37] 4. Clinical Trials: To translate circadian biology into clinical practice, well-designed clinical trials are needed to evaluate the safety, efficacy, and feasibility of circadian-based interventions for autoimmune diseases. Chronotherapy Trials: • Trials investigating time-specific drug administration in autoimmune diseases are critical to validating the benefits of chronotherapy. • Example: Studies comparing the efficacy of morning versus evening administration of glucocorticoids in RA patients have already demonstrated improved outcomes with circadian-aligned dosing.[38] Lifestyle Intervention Studies: • Clinical trials examining the impact of sleep hygiene, light exposure, and meal timing on autoimmune disease activity can establish evidence-based recommendations. • Example: A trial examining the role of melatonin supplementation in improving circadian alignment and reducing disease severity in lupus patients. Cross-Disciplinary Trials: • Trials that combine chronotherapy with other interventions, such as dietary modifications (chrononutrition) and exercise timing, could provide insights into synergistic benefits. • Example: A study exploring the combined effects of intermittent fasting and evening exercise on circadian regulation and immune function in MS patients. Biomarker-Driven Trials: Incorporating circadian biomarkers into clinical trial designs can enhance patient stratification and treatment monitoring. For example, selecting patients with specific cortisol or melatonin rhythms could help identify responders to chronotherapy. Adaptive Trial Designs: Adaptive trial designs that incorporate real-time data from wearable devices and digital biomarkers allow for dynamic adjustments to treatment protocols, improving trial efficiency and patient outcomes. Conclusion The future of autoimmune disease management lies in leveraging circadian biology to develop precision medicine approaches. Biomarkers for circadian health, personalized chronotherapy, systems biology approaches, and innovative clinical trials form the foundation of this paradigm shift. By embracing these advancements, clinicians and researchers can harness the full potential of circadian biology to improve the lives of individuals with autoimmune diseases. This integrated approach not only addresses the underlying mechanisms of circadianimmune interactions but also paves the way for novel, patient-centered therapeutic strategies. Circadian rhythms are foundational to immune system regulation, orchestrating a delicate balance between inflammation and tolerance. Disruption of these rhythms contributes significantly to the pathogenesis and progression of autoimmune diseases. By integrating circadian principles into clinical practice, through chronotherapy, lifestyle interventions, and novel molecular therapies, we can advance the management of autoimmune diseases. Future research should focus on developing personalized, circadian-informed strategies to unlock the full therapeutic potential of chronobiology. References 1. Awuah AW, Huang H, Kalmanovich J, Mehta A, Mikhailova T, Ng CJ, Rahman AT, Adebusoye TF, Tan KJ, Kamanousa K, Ferreira T, Roy S, Kundu M, Yarlagadda R, Mukerjee N, Alexiou A, Papadakis M: Circadian rhythm in systemic autoimmune conditions: Potential of chrono-immunology in clinical practice: A narrative review; Medicine (Baltimore), 2023 Aug 11;102(32):e34614. doi: 10.1097/MD.0000000000034614. 2. Foster RG. Sleep, circadian rhythms and health. Interface Focus. 2020; 10:20190098. 3. Hickie IB, Naismith SL, Robillard R, et al. Manipulating the sleepwake cycle and circadian rhythms to improve clinical management of major depression. BMC Med. 2013; 11:1–27. 4. Khan S, Nabi G, Yao L, et al. Health risks associated with genetic alterations in internal clock system by external factors. Int J Biol Sci. 2018; 14:791–8. 5. Reddy S, Reddy V, Sharma S. Physiology, Circadian Rhythm. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2022. Available at [access date April 21, 2023]. 6. Torres-Ruiz J, Sulli A, Cutolo M, et al. Air travel, circadian rhythms/hormones, and International Journal of Toxicological and Pharmacological Research e-ISSN: 0975-5160, p-ISSN:2820-2651 Daret al. International Journal of Toxicological and Pharmacological Research 219 autoimmunity. Clin Rev Allergy Immunol. 2017; 53:117–25. 7. Karagianni P, Tzioufas AG. Epigenetic perspectives on systemic autoimmune disease. J Autoimmun. 2019; 104:102315. 8. Zielinski MR, Systrom DM, Rose NR. Fatigue, sleep, and autoimmune and related disorders. Front Immunol. 2019; 10:1827. 9. Ramos-Casals M, Brito-Zerón P, Kostov B, et al. Google-driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with systemic autoimmune diseases. Autoimmun Rev. 2015; 14:670–9. 10. Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev. 2003; 2:119–25. 11. Tsokos GC, Lo MS, Reis PC, et al. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 2016; 12:716–30. 12. Wang L, Wang FS, Gershwin ME. Human autoimmune diseases: a comprehensive update. J Intern Med. 2015; 278:369–95. 13. Wahren-Herlenius M, Dörner T. Immunopathogenic mechanisms of systemic autoimmune disease. Lancet. 2013; 382:819– 31. 14. Garbarino S, Lanteri P, Bragazzi NL, et al. Role of sleep deprivation in immune-related disease risk and outcomes. Commun Biol. 2021; 4:1304. 15. Young KA, Munroe ME, Harley JB, et al. Less than 7 hours of sleep per night is associated with transitioning to systemic lupus erythematosus. Lupus. 2018; 27:1524–31. 16. Honma S. The mammalian circadian system: a hierarchical multi-oscillator structure for generating circadian rhythm. J Physiol Sci. 2018; 68:207–19. 17. Foster RG. Sleep, circadian rhythms and health. Interface Focus. 2020; 10:20190098. 18. Yoshida Y, Fujiki N, Nakajima T, et al. Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light–dark cycle and sleep–wake activities. Eur J Neurosci. 2001; 14:1075–81. 19. Zhang S, Zeitzer JM, Yoshida Y, et al. Lesions of the suprachiasmatic nucleus eliminate the daily rhythm of hypocretin-1 release. Sleep. 2004; 27:619–27. 20. Yamakawa GR, Brady RD, Sun M, et al. The interaction of the circadian and immune system: desynchrony as a pathological outcome to traumatic brain injury. Neurobiol Sleep Circadian Rhythms. 2020; 9:100058. 21. Comas M, Gordon CJ, Oliver BG, et al. A circadian based inflammatory response– implications for respiratory disease and treatment. Sleep SciPract. 2017; 1:1–9. 22. Guerrero-Vargas NN, Salgado-Delgado R, del Carmen Basualdo M, et al. Reciprocal interaction between the suprachiasmatic nucleus and the immune system tunes down the inflammatory response to lipopolysaccharide. J Neuroimmunol. 2014; 273:22–30. 23. Sangle SR, Tench CM, D’Cruz DP. Autoimmune rheumatic disease and sleep: a review. CurrOpinPulm Med. 2015; 21:553–6. 24. Palagini L, Tani C, Mauri M, et al. Sleep disorders and systemic lupus erythematosus. Lupus. 2014; 23:115–23. 25. Zhao Q, Deng N, Chen S, et al. Systemic lupus erythematosus is associated with negatively variable impacts on domains of sleep disturbances: a systematic review and metaanalysis. Psychol Health Med. 2018; 23:685– 97. 26. Kok VC, Horng JT, Hung GD, et al. Risk of autoimmune disease in adults with chronic insomnia requiring sleep-inducing pills: a population-based longitudinal study. J Gen Intern Med. 2016; 31:1019–26. 27. Chung WS, Lin CL, Kao CH. Association of systemic lupus erythematosus and sleep disorders: a nationwide population-based cohort study. Lupus. 2016; 25:382–8. 28. Hsiao YH, Chen YT, Tseng CM, et al. Sleep disorders and increased risk of autoimmune diseases in individuals without sleep apnea. Sleep. 2015; 38:581–6. 29. Sang N, Gao RC, and Zhang MY, et al. Causal relationship between sleep traits and risk of systemic lupus erythematosus: a two-sample Mendelian randomization study. Front Immunol. 2022; 13:918749. 30. Palma BD, Gabriel A, Jr, Colugnati FA, et al. Effects of sleep deprivation on the development of autoimmune disease in an experimental model of systemic lupus erythematosus. Am J Physiol RegulIntegr Comp Physiol. 2006; 291:R1527–32. 31. Rijo-Ferreira F, Takahashi JS. Genomics of circadian rhythms in health and disease. Genome Med. 2019; 11:1–6. 32. Sutton CE, Finlay CM, Raverdeau M, et al. Loss of the molecular clock in myeloid cells exacerbates T cellmediated CNS autoimmune disease. Nat Commun. 2017; 8:1923. 33. Scheiermann C, Gibbs J, Ince L, et al. clocking in to immunity. Nat Rev Immunol. 2018; 18:423–37. 34. Gibbs JE, Ray DW. The role of the circadian clock in rheumatoid arthritis. Arthritis Res Ther. 2013; 15:205–9. 35. Yoshida K, Hashimoto T, Sakai Y, et al. Involvement of the circadian rhythm and inflammatory cytokines in the pathogenesis of International Journal of Toxicological and Pharmacological Research e-ISSN: 0975-5160, p-ISSN:2820-2651 Daret al. International Journal of Toxicological and Pharmacological Research 220 rheumatoid arthritis. J Immunol Res. 2014; 2014:282495. 36. Liu X, Chen B, Huang Z, et al. Effects of poor sleep on the immune cell landscape as assessed by single-cell analysis. Commun Biol. 2021; 4:1325. 37. Gravano DM, Hoyer KK. Promotion and prevention of autoimmune disease by CD8+ T cells. J Autoimmun. 2013; 45:68–79. 38. Grant CR, Liberal R, and Mieli-Vergani G, et al. Regulatory T-cells in autoimmune diseases: challenges, controversies and – yet – unanswered questions. Autoimmun Rev. 2015; 14:105–16.